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Cells invest in an extensive network of factors to maintain protein homeostasis (proteostasis) 
and prevent the accumulation of potentially toxic protein aggregates. This proteostasis 
network (PN) comprises the machineries for the biogenesis, folding, conformational 
maintenance and degradation of proteins, with molecular chaperones as central 
coordinators. Here we review recent progress in understanding the modular architecture of 
the PN in mammalian cells and how it is modified during cell differentiation. We discuss the 
capacity and limitations of the PN in maintaining proteome integrity in the face of proteotoxic 
stresses, such as aggregate formation in neurodegenerative diseases. Finally, we outline 




Proteins are the most versatile macromolecules and are responsible for almost all cellular 
functions. An average human cell expresses approximately 10,000- 13,000 different protein 
species (Bekker-Jensen et al. 2017; Kulak et al. 2017), with copy numbers varying over 
several orders of magnitude, from a few molecules to tens of thousands. To maintain protein 
homeostasis, or proteostasis (Balchin et al. 2016), cells must ensure that these proteins fold 
and assemble correctly and exist in the right cellular locale at appropriate abundance.  
Most proteins must adopt a unique, thermodynamically stable three-dimensional 
structure, the functionally active state, that is determined by the amino acid sequence 
(Anfinsen 1973). Proteins must fold to this native state at biologically relevant timescales, a 
process that is increasingly well understood, at least for small model proteins that fold rapidly 
without detectable intermediate states (Dobson and Karplus 1999; Hartl and Hayer-Hartl 
2009). However, proteins with complex domain folds and multi-domain proteins, which make 
up the major part of the proteome, frequently populate folding intermediates that expose 
hydrophobic amino acid residues. These proteins are at risk of misfolding and aggregation 
within the highly crowded environment of the cell (Ellis and Minton 2006). Once folded, 
proteins must maintain their correct three-dimensional shape, which is complicated by the 
fact that functionality often requires considerable conformational flexibility. As a result, the 
folded states of many proteins are only marginally stable (or metastable) in the cellular 
milieu. Moreover, a considerable fraction of proteins (~30% in human cells) are either 
completely devoid of ordered structure (intrinsically disordered proteins; IDRs) or contain 
substantial unstructured regions (Dunker et al. 2008). These proteins typically only adopt 
folded structures upon binding to partner proteins, which emphasizes the importance of 
correct concentration and localization. Even natively structured proteins are constantly 
conformationally challenged in the face of a variety of endogenous and exogenous stresses. 
Proteins that fail to adopt or maintain their folded structure, for example due to mutation, as 
well as proteins which have served their function, must be removed by degradation to 
prevent deleterious consequences.  
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To maintain protein homeostasis and proper proteome balance, cells employ 
interconnected modules of factors collectively referred to as the proteostasis network (PN). 
This network comprises of cellular machineries for the biogenesis and degradation of 
proteins, with molecular chaperones as central coordinators mediating protein folding and 
conformational maintenance. Although early studies in yeast have enabled a basic 
understanding of the eukaryotic PN (Albanese et al. 2006; Finley et al. 2012), the PN in 
human cells is predicted to be far more complex (Klaips et al. 2018), owing to the diverse 
requirements of cell- and tissue- specific proteomes (Wilhelm et al. 2014; Uhlen et al. 2015). 
Loss of proteostasis is linked to ageing and several medical conditions associated 
with the formation of toxic protein aggregates, prominently including numerous 
neurodegenerative diseases like Alzheimer’s and Huntington’s disease, and other 
pathologies affecting many different cell types. The familial forms of these diseases have an 
underlying genetic cause in which mutations increase the likelihood of specific disease 
proteins to misfold and aggregate. Classic examples are forms of amyotrophic lateral 
sclerosis associated with mutations in superoxide dismutase and a group of disorders, 
including Huntington’s disease, that are caused by expanded polyglutamine tracts in 
otherwise unrelated proteins. Importantly, despite the presence of the respective mutation in 
all somatic tissues, most of these pathologies manifest in an age-dependent manner (age-
onset diseases), consistent with a decline in proteostasis capacity during aging being a 
critical risk factor (Taylor and Dillin 2011; Labbadia and Morimoto 2015; Higuchi-Sanabria et 
al. 2018). Moreover, in most cases specific cell types and tissues are exclusively or 
preferentially affected (Fu et al. 2018), suggesting an underlying heterogeneity between cell 
types in proteostasis capacity and the ability to respond to proteotoxic stress (Sala et al. 
2017).  
In this review we discuss recent progress in our understanding of the modular 
organization of the PN and its capacity to maintain proteome integrity in the face of stress 
conditions. Using the example of stem cells, we examine PN plasticity and rewiring during 
cell differentiation. We further discuss how the burden of toxic protein aggregates in disease 
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may cause proteostasis collapse. Finally, we outline various pharmacological interventions to 
ameliorate proteostasis imbalance as an attractive avenue towards therapeutic strategies for 
some proteinopathies.  
 
Organization of the Proteostasis Network 
Protein folding accuracy is fundamental to all cells. However, maintaining fidelity of protein 
synthesis and folding is confounded by the fact that the underlying genetic and biochemical 
systems are inherently error-prone, which leads to the constant production of a certain 
amount of misfolded proteins. This problem is further aggravated by genetic variation (single 
nucleotide polymorphisms) and the effects of environmental stress. The resulting aberrant 
proteins must be detected and degraded by the PN to prevent them from engaging in 
unwanted interactions and toxic protein aggregation. Chronic aggregate production can 
overwhelm the cellular capacity to maintain proteostasis and respond properly to proteotoxic 
stress (Olzscha et al. 2011; Roth et al. 2014). To maintain a balanced and healthy proteome, 
cells have evolved an integrated network of protein quality control factors (the PN) tending to 
the synthesis, folding, maintenance and timely turnover of proteins. For any given protein, 
the PN comprises all cellular factors required for folding upon synthesis and conformational 
maintenance at the correct location and appropriate concentration, and finally for controlled 
degradation once the protein has fulfilled its function or has undergone irreversible 
misfolding. 
In its simplest form the PN can be described by three major modules which govern 
each of these processes (Figure 1A and B): 1) protein synthesis; 2) folding and 
conformational maintenance by molecular chaperones and co-chaperones; and (3) protein 
degradation by the ubiquitin-proteasome system (UPS) and the autophagy-lysosomal 
pathway (ALP). These three modular branches coordinately tune the health of the proteome 
with molecular chaperones being central to their interconnectivity. Besides PN components 
that are required generally, such as ribosomes, proteasomes and lysosomes, there is likely a 
requirement for ‘specific’ factors tailored to certain proteins (or sets of proteins) with distinct 
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properties. Additionally, proteostasis within organelles such as the endoplasmic reticulum 
(ER) and mitochondria requires specialized factors and chaperones for protein trafficking and 
folding (Hetz et al. 2015; Moehle et al. 2018). Due to this inherent complexity, the 
composition of the PN remains poorly defined. However, advances in understanding the 
functional annotation of components belonging to each individual module allows an 




Cytosolic ribosomes and associated factors produce the bulk of the cellular proteome at an 
average rate of 5-6 amino acids per second (Ingolia et al. 2011), generating over a billion 
protein molecules per human cell (Milo 2013) with an average size of 560 amino acids (Wolff 
et al. 2014; Balchin et al. 2016). However, this process is error-prone with a misincorporation 
rate of 1 in 104 amino acids (Zaher and Green 2009). As a result, roughly 1 in 20 protein 
molecules contains a sequence error, potentially causing misfolding or reduced stability. 
Defective protein products can also arise due to posttranscriptional splicing errors or 
production of defective mRNA. For example, erroneous mRNA molecules that lack stop 
codons cause ribosome stalling during translation. In these cases the defective mRNAs are 
removed by cellular RNA surveillance pathways (Doma and Parker 2007; Isken and Maquat 
2007), and the translated nascent protein chain is degraded by the ribosome associated 
quality control (RQC) pathway (Brandman and Hegde 2016; Joazeiro 2017), which senses 
ribosome-stalled polypeptides and engages UPS components to degrade them. Failure of 
the RQC machinery leads to protein aggregation and proteotoxic stress (Choe et al. 2016; 
Yonashiro et al. 2016; Izawa et al. 2017), and to age-dependent neurodegeneration in a 
mouse model (Chu et al. 2009). tRNA availability may limit translation rates and result in 
protein aggregation, perhaps by increasing the likelihood of misreading or frameshifts, or by 
increasing the risk that nascent chains occupy non-productive folding intermediates 
(Nedialkova and Leidel 2015). Notably, the rate of protein synthesis is also dynamically 
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regulated in response to a variety of stimuli, both globally and in a protein-specific manner. 
During conditions of proteotoxic stress, a programmed decrease in protein synthesis 
(Spriggs et al. 2010) is initiated (Figure 1B) to alleviate the load of newly-synthesized 
proteins that must be folded by the PN. Upon conformational stress in the ER or activation of 
the integrated stress response, this is accomplished by phosphorylation of the translation 
initiation factor eIF2α (Pakos-Zebrucka et al. 2016; Karagöz et al. this vol.). 
 
Folding and Conformational Maintenance  
As shown recently, some small proteins can undergo partial or complete folding within the 
exit tunnel of the ribosome (Holtkamp et al. 2015; Nilsson et al. 2015). However, for the 
majority of larger proteins, folding is thought to begin once a chain segment sufficient to 
specify a cooperatively folding domain has emerged from the ribosome, followed by 
completion of folding upon chain release (Balchin et al. 2016). Multi-domain proteins may 
fold their domains co-translationally in a sequential manner, thereby reducing the problem of 
folding a large protein to the folding of smaller modules (Kim et al. 2013).  
Both co- and post-translational folding is assisted by molecular chaperones (Figure 
1B), which prevent or reverse misfolding events and favor productive folding pathways. 
Molecular chaperones are defined as factors which assist in the folding (and often assembly) 
of another protein without being part of its final structure (Hartl 1996).  
The human genome encodes ~332 chaperones and co-chaperones (referred to as 
the ‘chaperome’) (Brehme et al. 2014) (Figure 1A). Chaperones are broadly grouped by 
molecular weight and many are classified as heat shock proteins (Hsp), due to their induction 
upon exposure of cells to elevated temperature and other forms of proteome stress. The 
main classes of chaperones (88 proteins) include the ATP-dependent Hsp70s, Hsp90s, 
Hsp60s (also called chaperonins) and Hsp100s, and the ATP-independent small heat shock 
proteins (sHsps). They are assisted by regulatory co-chaperones (244 proteins) that further 
impart substrate specificity and selectivity. The major groups of co-chaperones are the 
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Hsp40s (49 proteins), as regulators of the Hsp70s, and the tetratricopeptide repeat proteins 
(TPR) (114), as regulators of the Hsp90 system (Table 1). 
Chaperones serve as the main conductors of proteostasis by directly influencing the 
‘foldedness’ of the proteome. They typically do so by binding to hydrophobic polypeptide 
segments that are exposed by non-native proteins but are buried in the native state, thus 
preventing aggregation and maintaining the polypeptide in a folding-competent state. The 
ATP-dependent chaperones (Hsp70, Hsp90, chaperonins) promote folding through ATP-
regulated cycles of binding and release during which the client protein reaches its final 
structure, sometimes through an accelerated folding pathway (Hartl et al. 2011; Balchin et al. 
2016). In some cases, proteins are altogether unable to fold without the aid of chaperones, 
defining the limit of the Anfinsen dogma. One such case is the cytoskeletal protein actin 
(Balchin et al. 2018). 
Chaperones act in the folding of newly-synthesized polypeptides either in association 
with the ribosome (e.g. the mammalian ribosome associated complex RAC and specialized 
Hsp70s (HSP70L1) (Preissler and Deuerling 2012; Kramer et al. 2018) or downstream of the 
ribosome upon polypeptide release, such as the classical Hsp70s, Hsp90s and the 
TRiC/CCT chaperonin (Figure 1B). TRiC (and the chaperonins in mitochondria, Hsp60, and 
bacteria, GroEL) are large ~1 MDa double-ring complexes that transiently enclose a single 
molecule of unfolded substrate protein in a cage-like structure, allowing folding to occur 
unimpaired by aggregation (Balchin et al. 2016; Hayer-Hartl et al. 2016). The ATP-
independent sHsps function as ‘holdases’ in stabilizing proteins against aggregation or in 
shielding the surfaces of aggregates (Carra et al. 2017).  
Molecular chaperones cooperate in cellular folding pathways, as shown for the 
bacterial and eukaryotic cytosol and in other systems (Langer et al. 1992; Frydman et al. 
1994; Frydman 2001). Indeed, different chaperones interact to form modules and functional 
supercomplexes (Rizzolo et al. 2017). Specific chaperone pathways for the diverse array of 
protein clients can be perceived as a sequential percolator: proteins that fold rapidly upon 
interaction with upstream chaperones, like the Hsp70s, would not require more specialized 
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downstream chaperones, whereas proteins that fail to fold with the upstream chaperones will 
filter down to Hsp90 or the chaperonin to attain their folded functional state (Hartl 1996). 
Quantitative analyses of client proteins for specific chaperones in simpler model 
systems like E. coli (Kerner et al. 2005; Oh et al. 2011; Calloni et al. 2012) have revealed 
features of client flux through the bacterial chaperone network. Similar studies in S. 
cerevisiae have yielded a systems view of the eukaryotic chaperone network (Zhao et al. 
2005; Gong et al. 2009; Willmund et al. 2013). Chaperone-dependent proteins are frequently 
larger than average, containing multiple domains or domains with complex fold topologies, 
typically characterized by many long-range interactions. Salient features of the eukaryotic 
chaperone network have emerged from systematic mapping of the interactions of 
chaperones and co-chaperone with their clients. It has been shown for yeast cells that the 
‘chaperome’ can be divided into components that are mainly devoted to the folding of newly-
synthesized proteins and components that function in conformational maintenance (Albanese 
et al. 2006). The former include the ribosome-binding chaperones that are not stress-
inducible, whereas the latter include the classic stress-inducible chaperones.  
In humans and other mammals the chaperome has expanded to match the needs of 
a larger and more complex proteome (Powers and Balch 2013). While the PN of human cells 
has not yet been comprehensively characterized, recent studies focused on the substrate 
interactome of Hsp90, a chaperone system thought to be specifically devoted to kinases and 
other signaling proteins (Mymrikov et al. 2017). In an initial survey of ~2000 candidates 
comprising kinases, transcription factors (TFs) and E3 ligases, 200 of 355 kinases and ~120 
of 426 ubiquitin E3 ligases analyzed were found to utilize Hsp90 for folding or conformational 
regulation, while TFs showed no such preference (50 Hsp90 substrates among 1100 TFs 
tested) (Taipale et al. 2012). The finding that E3 ligases are clients of the folding machinery 
further emphasizes the interconnectivity of the folding and degradation modules of the PN. A 
more comprehensive investigation (Taipale et al. 2014) including ~70 chaperones, co-
chaperones and protein quality control factors revealed a hierarchical organization of the 
chaperone network centered on the interconnected Hsp70 and Hsp90 chaperone systems. 
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More recently, an integrated chaperone network that supports cell survival was observed in 
cancer cells to be essential for tumor maintenance. This complex called the ‘epichaperome’ 
(Rodina et al. 2016) is formed by an enhanced physical interaction of the Hsp70 and Hsp90 
machineries along with their co-chaperones. 
A key question regarding chaperone networks is how client flux is redirected when 
one chaperone system is overwhelmed. Similar to findings in bacterial cells where mutual 
compensation among chaperone systems is observed (Deuerling et al. 1999; Teter et al. 
1999; Calloni et al. 2012), inhibition of Hsp90 in human cells promoted client binding to 
Hsc70, the constitutively expressed Hsp70 (Taipale et al. 2014). Among the BAG family co-
chaperones, which function as nucleotide exchange factors of Hsp70, only BAG2 proved to 
have a client range similar to Hsc70, suggesting that it is a general co-factor involved in the 
folding pathway of Hsc70 substrate proteins. The interaction spectrum of Hsc70 also 
correlates with that of the E3 ligase CHIP (carboxy-terminus of Hsp70-interacting protein), 
again pointing to a functional co-operation between chaperones and the UPS (Esser et al. 
2004; Kundrat and Regan 2010).  While these studies have provided initial insights into how 
substrate proteins are distributed within the chaperome, it remains to be established how 
exactly client specificity and selectivity is achieved. Within the Hsp70 system, the Hsp40 
cofactors (~50 different proteins in human) play a central role in this process (Kampinga and 
Craig 2010) (Table 1). 
While the majority of chaperone systems function to prevent protein aggregation, 
certain chaperones are specialized to act as “disaggregases” and actively dissolve protein 
aggregates (Mogk et al. 2018) (Figure 1B). A well-studied example is yeast Hsp104, which 
performs disaggregation in an ATP-driven manner (Parsell et al. 1994) in cooperation with 
Hsp70 and Hsp40 (Mogk et al. 2015). In metazoans, which lack Hsp104, disaggregation of 
stress induced aggregates is enabled by Hsp70 in cooperation with Hsp110 (a Hsp70-like 
protein that functions as nucleotide exchange factor for Hsp70), Hsp40s and sHsps 





The steady-state concentration of proteins is the result of a balance between protein 
synthesis and degradation. Cells are equipped with efficient protein degradation machineries 
which recycle proteins once they are no longer needed and remove misfolded proteins in 
order to prevent the formation of potentially toxic aggregates. Eukaryotic cells employ two 
main degradation machineries, the UPS and the autophagy lysosomal pathway (ALP) 
(Forster et al. 2013; Cohen-Kaplan et al. 2016; Dikic 2017; Varshavsky 2017). The UPS 
serves as the major pathway of protein degradation and is responsible for ~80% of protein 
turnover (Zhao et al. 2015; Collins and Goldberg 2017). Central to the UPS is the 26S 
proteasome, a large multisubunit protease complex (Forster et al. 2013; Livneh et al. 2016). 
The 26S proteasome recognizes substrates after their covalent modification with the small 
protein ubiquitin. Ubiquitylation of target proteins is a highly regulated process that is 
catalyzed in an ATP dependent manner by a cascade of ubiquitin activating enzymes (E1), 
ubiquitin conjugating enzymes (E2) and ubiquitin ligases (E3) (Finley 2009; Zheng and 
Shabek 2017). Of the ~2000 PN components, the UPS constitutes the largest group with 
~850 proteins (Klaips et al. 2018), ~600 of which are E3 ligases (Li et al. 2008) (Figure 1A). 
The catalytic sites of the proteasome are buried within the central cavity of the 20S catalytic 
unit, and can only be accessed if the protein substrate is able to pass a narrow entrance into 
the catalytic core. To achieve this passage, most proteins need to be unfolded in an ATP-
dependent reaction catalyzed by the 19S regulatory particle that caps the 20S core 
(Bhattacharyya et al. 2014). Recent cryoelectron microscopy analyses of the proteasome 
with substrate protein engaged provide mechanistic insight into this complex process (Beck 
et al. 2012; de la Pena et al. 2018; Dong et al. 2019). Owing to the requirement for substrate 
unfolding, the proteasome is unable to degrade aggregated proteins directly, and 
disaggregation by chaperone machinery is a prerequisite. More generally, chaperones 
function to stabilize misfolded proteins in a non-aggregated state competent for ubiquitin 
tagging and delivery to the proteasome (Esser et al. 2004). A chaperone-bound protein may 
be triaged for degradation by ubiquitylation when (re)folding is unsuccessful, resulting in a 
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prolonged chaperone residence time. The E3 ligase CHIP interacts directly with Hsp70 to 
ubiquitylate chaperone-bound proteins. Up to a certain point this modification may still be 
reversed by ubiquitin hydrolases (Mevissen and Komander 2017). How these opposing 
reactions are fine-tuned is central to understanding the mechanisms of protein quality 
control. 
Despite the presence of the UPS, protein misfolding nevertheless leads to the 
formation of insoluble aggregates and larger inclusions, especially under stress conditions. In 
contrast to the UPS, autophagy coupled to lysosomal degradation has the capacity to directly 
remove such aggregates (Figure 1B). In this process, aggregates or fragments thereof are 
engulfed by double-membrane structures (autophagosomes), which then fuse with the 
lysosome (Galluzzi et al. 2017). While the core machinery of autophagy consists of only 17 
proteins (Dikic 2017), the ALP system including accessory factors comprises a total of ~500 
components (Garcia-Prat et al. 2016). Aggregated proteins accumulate in ubiquitin positive 
deposits to which the autophagic machinery is recruited by chaperones in a process known 
as chaperone-assisted selective autophagy (CASA) (Carra et al. 2008; Gamerdinger et al. 
2009; Arndt et al. 2010). Under basal conditions in mammalian cells, soluble proteins can 
also be degraded by a specific form of autophagy called chaperone-mediated-autophagy 
(CMA), which involves substrate recognition and unfolding by Hsc70 and direct lysosomal 
translocation by binding to the lysosomal receptor LAMP2A, without the need for 
autophagosome formation (Kaushik and Cuervo 2018) (Figure 1B). While both the UPS and 
the ALP display a certain degree of specificity regarding their range and diversity of 
substrates, they are functionally interconnected and often compensate one another under 
conditions where one pathway is saturated or malfunctional (Suraweera et al. 2012; Zhang et 
al. 2016; Dikic 2017) – another reflection of the network character of the PN.   
 
Stress Response Pathways  
Many natively folded proteins are metastable under normal cellular growth conditions (i.e. 
they reside at the limit of thermodynamic stability or contain substantial IDRs). Exposing cells 
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to proteome stress, such as heat stress, then results in (partial) protein unfolding and 
possible aggregation. To deal with such stress situations, cells have evolved compartment-
specific transcriptional stress response pathways (Figure 2), prominently including the 
cytosolic heat stress response (HSR) (Morimoto 2011) and the unfolded protein response 
pathways of the ER (UPRER) (Walter and Ron 2011; Karagöz et al. this vol.) and 
mitochondria (UPRMito) (Melber and Haynes 2018; Naresh and Haynes, this vol.).  
Activation of the HSR leads to the induction of molecular chaperones (Hsps) and 
other quality control components, which act to prevent protein aggregation and mediate 
protein refolding or degradation via the UPS (Richter et al. 2010). The selective induction of 
molecular chaperones is accompanied by a global decrease in protein synthesis, particularly 
through attenuation of translational elongation (Liu et al. 2013; Shalgi et al. 2013), thus 
reducing the burden on the folding machinery and making proteostasis capacity available for 
conformational maintenance and clearance of misfolded proteins (Figure 2). Induction of the 
HSR is not limited to acute abiotic stresses such as heat or a change in pH, but is also 
mediated by other proteotoxic insults, such as the expression of certain misfolding mutant 
proteins at normal cellular growth temperatures (Geiler-Samerotte et al. 2011). 
The eukaryotic HSR is mediated by heat shock factor 1 (HSF1) as the master 
transcription factor (Vabulas et al. 2010; Anckar and Sistonen 2011). Under normal 
conditions, HSF1 exists as a monomer bound by chaperones (Zou et al. 1998; Neef et al. 
2014; Zheng et al. 2016). While HSF1 controls the expression of thousands of genes, its key 
function under conditions of proteotoxic stress is the tight regulation of a small set of 
chaperone genes (Mahat et al. 2016; Solis et al. 2016). The current model of the HSR posits 
that production of misfolded proteins under conditions of stress titrates away the chaperones 
bound to HSF1, which allows HSF1 to trimerize and become transcriptionally active. The 
resulting increase in chaperone levels provides a negative feedback loop that deactivates 
HSF1 once a sufficient amount of free chaperones is restored (Krakowiak et al. 2018). 
Additional mechanisms of attenuation of the HSR include HSF1 degradation and cycles of 
acetylation and deacetylation (Westerheide et al. 2009; Raychaudhuri et al. 2014). 
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While it is unclear what fraction of the mammalian proteome denatures and misfolds 
during heat stress (Wallace et al. 2015), the level of ubiquitylated proteins rapidly increases 
in stressed cells (Fujimuro et al. 1997), suggesting that degradation of misfolded proteins via 
the UPS is critical in reestablishing proteome balance (Parag et al. 1987). Nascent 
polypeptides synthesized prior to heat stress, possibly still bound to ribosomes in unfolded 
states, are thought to represent the major vulnerable fraction of the proteome that is targeted 
for degradation (Medicherla and Goldberg 2008; Xu et al. 2016). A comprehensive genome-
wide deletion screen for induction of the HSR in yeast (Brandman et al. 2012) under non-
stress conditions revealed an enrichment of individual chaperones and members of the UPS 
among other inducers, pointing to a strong cross-talk between the two PN modules. Future 
genome-wide efforts to study proteostasis in mammalian cells will be facilitated by the advent 
of pooled CRISPR screens (Shalem et al. 2014) and haploid genetic screens (Brockmann et 
al. 2017). While protein degradation via the UPS has been classically associated with the 
HSR, studies in the nematode C. elegans (Kumsta et al. 2017) and in mammalian cells 
(Watanabe et al. 2017) demonstrated a direct link between the HSR and autophagy, thus 
providing further evidence for a highly interconnected PN with modular flexibility. 
 
The Proteostasis Network in Cell Differentiation 
All existing tissues and cell types within the human body are a result of well-defined 
programs of stem cell division and differentiation. While embryonic stem cells (ESCs) 
represent the reservoir of pluripotent cells and thus shape development early in life, postnatal 
maintenance of tissue homeostasis is conducted by specialized multi-potent adult stem cells 
(e.g. neuronal stem cells and satellite stem cells in muscles) within their respective niches. 
Regardless of their origins, stem cells must continuously replenish their numbers via 
asymmetric cell division (segregating cell fate determinants into only one of the two daughter 
cells) (Knoblich 2008), while maintaining a damage-free proteome. At the same time, they 
have to remodel their proteomes as they differentiate into various fates, which emphasizes 
the importance of proteostasis control and PN rewiring in development (Vilchez et al. 2014). 
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Stem cells are thought to have a higher proteostasis capacity than differentiated cells. 
Lower rates of protein synthesis in adult hematopoietic, neural, epidermal and muscle stem 
cells (Signer et al. 2014; Llorens-Bobadilla et al. 2015; Blanco et al. 2016; Zismanov et al. 
2016) presumably result in a reduced burden on the folding module of the PN. In contrast, 
ESCs tend to have higher translational rates (Ingolia et al. 2011; You et al. 2015). This 
difference can be attributed to the higher proliferative activity of ESCs (Garcia-Prat et al. 
2017). Important differences have also been noted in the composition of the stem cell 
chaperome (Figure 3A and B). ESCs have higher levels of a subset of chaperones, such as 
the chaperonin TRiC/CCT, which decreases as cells differentiate into neuronal progenitors 
and neurons (Noormohammadi et al. 2016). The high demand for TRiC/CCT may be related 
to the folding requirements of actin (Yam et al. 2008; Balchin et al. 2018), which is 
increasingly needed in proliferating ESCs for cytoskeletal synthesis and integrity. Mouse 
ESCs have also been found to have increased levels of stress inducible cytosolic Hsp70 
(HSPA1), a strong target of HSF1 (Saretzki et al. 2004; Saretzki et al. 2008). Hsp70 levels 
decrease as the cells differentiate, which may point to a dampened stress response. Indeed, 
neural differentiation from progenitor cells results in a marked reduction of HSR inducibility 
(Yang et al. 2008) (Figure 3A), suggesting that neurons may inherently be more vulnerable to 
proteome stress. It remains to be seen, whether this is generally true for other differentiated 
tissues. 
Stem cells are also equipped with enhanced protein degradation capacity, 
presumably allowing for the effective removal of misfolded proteins. Studies in ESCs 
demonstrated higher levels of proteasome activity associated with an increase of the 19S 
regulatory subunit PSMD11, which is limiting for 26S proteasome assembly (Vilchez et al. 
2012). Proteasome activity decreased during differentiation into several lineages.  
An extreme case of PN rewiring and proteome remodeling is the recently described 
mechanism of terminal differentiation of reticulocytes into erythrocytes (red blood cells) within 
the hematopoietic lineage (Nguyen et al. 2017). Erythrocytes are unique cells whose 
proteome is composed to almost 98% of a single protein – hemoglobin. As reticulocytes 
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differentiate into erythrocytes, most of their proteome is degraded and replaced by 
hemoglobin. Surprisingly, the determinant of such a global process is a single E2-E3 hybrid 
ligase, UBE2O, which encodes activities for multiple components of a quality control pathway 
– substrate recognition (in lieu of a chaperone), ubiquitin transfer (E2) and ubiquitin 
conjugation (E3). UBE2O was also found to be responsible for the removal of ribosomal 
proteins via the proteasome, a hallmark of erythrocyte development. UBE2O also clears 
unassembled globin chains, thus serving as an essential quality control factor during this 
transition (Yanagitani et al. 2017). This unique process exemplifies extensive rewiring of PN 
modules. 
 
Ameliorating Proteinopathies  
PN deregulation and decline during aging has been recognized as a major driver of many 
proteinopathies, especially affecting the more vulnerable populations of postmitotic neuronal 
cells (Dillin and Cohen 2011; Gidalevitz et al. 2011; Morimoto, this vol.). These age-onset 
pathologies include Alzheimer’s, Parkinson’s and Huntington’s diseases, as well as 
amyotrophic lateral sclerosis and other pathologies. All these disorders are characterized by 
the formation of soluble, oligomeric and insoluble, fibrillar aggregates that exert cytotoxic 
effects (Chiti and Dobson 2017; Iadanza et al. 2018). Of particular importance in 
understanding the progressive nature of these diseases is that the aggregates subvert the 
function of the PN at several levels, for example by sequestering critical chaperone 
components and degradation machinery into aggregate inclusions (Rubinsztein 2006; Park 
et al. 2013; Yu et al. 2014; Guo et al. 2018; Thibaudeau et al. 2018), by overburdening the 
UPS (Bence et al. 2001; Bennett et al. 2007; Hipp et al. 2012), and by reducing the cellular 
capacity to respond to additional stresses (Labbadia et al. 2011; Olzscha et al. 2011; Roth et 
al. 2014). As a result, affected cells gradually lose the ability to cope with misfolding proteins, 
which in turn increases aggregate burden, setting in motion a vicious cycle that ends in 
proteostasis collapse and cell death (Hipp et al. 2014). 
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Since the PN is inherently modular and adaptable to stress, exploring ways to boost 
proteostasis could provide therapeutically viable options to decrease disease severity and 
slow progression (Balch et al. 2008; Powers et al. 2009; Hipp et al. 2014). Evidence has 
been provided that molecular chaperones, especially Hsp70 and Hsp40, can prevent 
formation of amyloid fibers (Muchowski et al. 2000) or disaggregate them (Gao et al. 2015), 
demonstrating the potential of modulating the PN to combat proteinopathies in vivo. 
Accordingly, pharmacological induction or genetic overexpression of molecular chaperones 
has been shown to prevent aggregation in cellular (Sittler et al. 2001) and animal models 
(Labbadia et al. 2012; Kakkar et al. 2016; Nagy et al. 2016; Scior et al. 2018).  
While boosting chaperone activities has shown promise, tuning the other PN modules 
may also enhance proteostasis capacity. Small molecule based modulation of the UPS (Lee 
et al. 2010; Leestemaker et al. 2017) and autophagy (Sarkar et al. 2009; Barmada et al. 
2014; Kuo et al. 2015) augments clearance of protein aggregates and improves cellular 
health. Furthermore, stress responses to protein misfolding often culminate in translational 
attenuation to reduce downstream burden on the folding and degradation arm of the PN 
(Figure 2). Reducing the level of newly-synthesized proteins is therefore another promising 
approach to combat protein misfolding. Indeed, the pharmacologic prolongation of stress-
induced translational attenuation has been shown to be beneficial in protein misfolding 
disorders (Tsaytler et al. 2011; Das et al. 2015).  
 
Concluding Remarks 
Maintenance of proteostasis is central to cellular health, and its impairment is causally linked 
to neurodegenerative proteinopathies and numerous other pathologies. Advances over the 
past two decades have laid the foundation for our understanding of the architecture of the 
proteostasis network. The modular and adaptive nature of the PN enables cells to handle 
changing proteomic requirements during cellular development and endure adverse 
conditions brought about by various endogenous and environmental stresses. Although we 
currently have only a bird’s eye view of how the PN is organized and how many components 
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may be involved in proteostasis maintenance, future studies will hopefully tease apart the 
complex and specific PN connectivities in tissues that are particularly vulnerable to 
proteostasis collapse. Progress resulting from such studies will be especially relevant in 
developing urgently needed treatments for the group of neurodegenerative proteinopathies. 
Protein misfolding and aggregation in these diseases results in a gain of function toxicity 
which eventually overwhelms the capacity of the PN to maintain proteostasis. Enhancing 






Table 1. Chaperone classification in human cells (from Brehme et al. 2014) 































Figure 1. Architecture of the proteostasis network (PN). 
A. The three modules of the PN (outer ring) – synthesis (blue – 274 factors), folding and 
conformational maintenance (green – 332 factors) and degradation (brown – 1382 factors). 
The inner pie chart shows the partitioning of each module into essential (hatched sectors – 
synthesis (203/274), folding (78/332) and degradation (178/1382)) and nonessential 
components (filled sectors).    
B. Central role of molecular chaperones in the PN. The nascent polypeptide chain emerging 
from the ribosomal tunnel is prevented from misfolding and aggregation by chaperones, 
including components that bind to the ribosome (Trigger factor in bacteria, Nascent chain 
associated complex (NAC) and ribosome associated complex (RAC) in eukarya). A second 
tier of chaperones (Hsp70, Hsp90, chaperonins) does not interact with the ribosome directly 
and mediate co- or post-translational folding. Proteins that misfold due to mutations or under 
conditions of stress are selectively degraded either by the ubiquitin proteasome system 
(UPS) or by chaperone-mediated autophagy (CMA) and chaperone-mediated selective 
autophagy (CASA). Misfolded proteins may aggregate to soluble oligomers, amorphous 
aggregates or amyloid fibrils when basal chaperone and degradation capacity is exceeded. 
Aggregates may be sequestered into insoluble inclusions, which may be dissociated into 
fragments by specialized chaperones (Hsp104 in yeast, Hsp70/Hsp40/Hsp110 in metazoans) 
for subsequent clearance by the autophagy/lysosomal pathway (APL).  
 
Figure 2. Proteostasis capacity and stress responses. 
During proteotoxic stress in different cellular compartments, proteostasis capacity is adjusted 
to meet increased cellular requirements. Global translational attenuation (1) reduces the 
burden on the folding machineries to free chaperone capacities for assistance in clearance of 
misfolded and aggregated species (2). Concomitantly, transcriptional stress responses 
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pathways are activated (3) to increase chaperone pools available for folding and 
degradation.  
 
Figure 3. Proteostasis network rewiring and decline in proteostasis capacity during cell 
differentiation. 
A. Human embryonic stem cells (hESC) have a higher proteostasis capacity as compared to 
differentiated cells, such as neurons. As hESC differentiate to neurons, the chaperonins 
(cytosolic TRiC/CCT and mitochondrial Hsp60) decrease in abundance and there is a 
general decline in degradation capacity. Additionally, differentiated neurons are less efficient 
in mounting a stress response in comparison to their progenitors and stem cells.  
B. Chaperome trajectories during neuronal differentiation of hESC (332 proteins analyzed). 
The chaperome landscape changes in abundance (indicated as log2 fold change) sampled 
on each day as hESC are differentiated into neurons. Chaperones can increase (left), 
decrease (middle) or remain unchanged in abundance (right) during this process. Prominent 
examples of each cluster are shown (BAG1/BAG3, regulators of Hsp70/Hsc70; CRYAB, a-
crystallin B chain; TRiC, cytosolic chaperonin; HSPD1, mitochondrial Hsp60; HSPA1, Hsp70; 
DNAJB1, Hsp40 regulator of Hsp70/Hsc70; HSPA8, Hsc70). Data for time dependent 
changes in chaperone abundance values were derived from Sequence Read Archive (SRA) 
accession number GSE86985 (Yao et al. 2017). TPM (transcripts per million) values were 
directly used to calculate clustering of chaperone trajectories using the fuzzy c-means 
algorithm Mfuzz (Kumar and Futschik 2007) with ‘m’ values set at 2 and a minimum 
membership cutoff of 0.8. The gradient from red to blue indicates high to low membership 
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